MAP Pharmaceuticals Presents Analyses Showing LEVADEX Effective when Administered at Various Times in Migraine Cycle …
MAP Pharmaceuticals Presents Analyses Showing LEVADEX Effective when Administered at Various Times in Migraine Cycle …
MAP Pharmaceuticals, Inc. announced today it will present new analyses from the FREEDOM-301 Phase 3 clinical trial in a late breaker session at the 52nd Annual Scientific Meeting of the American Headache Society in Los Angeles, California on Friday, June 25 from 3:30 to 4:00 pm PT.
Read more on PR Newswire via Yahoo! Finance
Related posts:
- MAP Pharmaceuticals to present new analyses on LEVADEX from FREEDOM-301 Phase 3 clinical trial
- Menstral cycle migraine headache remedies ?
- Migraine Headaches Relief ? 5 Effective Natural Remedies
- Effective Natural Cures for Childhood Migraine Headaches
- Migraine Headache Remedy - 4 Effective Methods To Get Migraine Headache Relief